These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 20574056)
41. Dose response effects of lisdexamfetamine dimesylate treatment in adults with ADHD: an exploratory study. Faraone SV; Spencer TJ; Kollins SH; Glatt SJ; Goodman D J Atten Disord; 2012 Feb; 16(2):118-27. PubMed ID: 21527575 [TBL] [Abstract][Full Text] [Related]
42. Treatment With Lisdexamfetamine Dimesylate Improves Self- and Informant-Rated Executive Function Behaviors and Clinician- and Informant-Rated ADHD Symptoms in Adults: Data From a Randomized, Double-Blind, Placebo-Controlled Study. Weisler R; Ginsberg L; Dirks B; Deas P; Adeyi B; Adler LA J Atten Disord; 2017 Dec; 21(14):1198-1207. PubMed ID: 24464328 [TBL] [Abstract][Full Text] [Related]
43. Sleep in children with attention-deficit hyperactivity disorder (ADHD): a review of naturalistic and stimulant intervention studies. Cohen-Zion M; Ancoli-Israel S Sleep Med Rev; 2004 Oct; 8(5):379-402. PubMed ID: 15336238 [TBL] [Abstract][Full Text] [Related]
44. Effects of lisdexamfetamine dimesylate treatment for ADHD on growth. Faraone SV; Spencer TJ; Kollins SH; Glatt SJ J Am Acad Child Adolesc Psychiatry; 2010 Jan; 49(1):24-32. PubMed ID: 20215923 [TBL] [Abstract][Full Text] [Related]
45. A cardiopulmonary study of lisdexamfetamine in adults with attention-deficit/hyperactivity disorder. Hammerness P; Zusman R; Systrom D; Surman C; Baggish A; Schillinger M; Shelley-Abrahamson R; Wilens TE World J Biol Psychiatry; 2013 May; 14(4):299-306. PubMed ID: 22559155 [TBL] [Abstract][Full Text] [Related]
46. Onset of efficacy of long-acting psychostimulants in pediatric attention-deficit/hyperactivity disorder. Brams M; Mao AR; Doyle RL Postgrad Med; 2008 Sep; 120(3):69-88. PubMed ID: 18824827 [TBL] [Abstract][Full Text] [Related]
47. The sleep of children with attention deficit hyperactivity disorder on and off methylphenidate: a matched case-control study. Galland BC; Tripp EG; Taylor BJ J Sleep Res; 2010 Jun; 19(2):366-73. PubMed ID: 20050995 [TBL] [Abstract][Full Text] [Related]
48. Evaluation of risks associated with short- and long-term psychostimulant therapy for treatment of ADHD in children. Kociancic T; Reed MD; Findling RL Expert Opin Drug Saf; 2004 Mar; 3(2):93-100. PubMed ID: 15006715 [TBL] [Abstract][Full Text] [Related]
49. Sex subgroup analysis of treatment response to lisdexamfetamine dimesylate in children aged 6 to 12 years with attention-deficit/hyperactivity disorder. McGough JJ; Greenbaum M; Adeyi B; Babcock T; Scheckner B; Dirks B; Findling RL J Clin Psychopharmacol; 2012 Feb; 32(1):138-40. PubMed ID: 22217951 [No Abstract] [Full Text] [Related]
50. Reading performance as a function of treatment with lisdexamfetamine dimesylate in elementary school children diagnosed with ADHD. Wigal SB; Maltas S; Crinella F; Stehli A; Steinhoff K; Lakes K; Schuck S J Atten Disord; 2012 Jan; 16(1):23-33. PubMed ID: 20978273 [TBL] [Abstract][Full Text] [Related]
51. Sleep disturbances in children with attention-deficit/hyperactivity disorder. Corkum P; Tannock R; Moldofsky H J Am Acad Child Adolesc Psychiatry; 1998 Jun; 37(6):637-46. PubMed ID: 9628084 [TBL] [Abstract][Full Text] [Related]
52. The use of lisdexamfetamine dimesylate for the treatment of ADHD and other psychiatric disorders. Roncero C; Álvarez FJ Expert Rev Neurother; 2014 Aug; 14(8):849-65. PubMed ID: 24948428 [TBL] [Abstract][Full Text] [Related]
53. Pilot study of the effects of lisdexamfetamine on cocaine use: A randomized, double-blind, placebo-controlled trial. Mooney ME; Herin DV; Specker S; Babb D; Levin FR; Grabowski J Drug Alcohol Depend; 2015 Aug; 153():94-103. PubMed ID: 26116930 [TBL] [Abstract][Full Text] [Related]
54. Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder. Corkum P; Panton R; Ironside S; Macpherson M; Williams T J Pediatr Psychol; 2008 May; 33(4):368-79. PubMed ID: 18056144 [TBL] [Abstract][Full Text] [Related]
55. Effects of once-daily oral and transdermal methylphenidate on sleep behavior of children with ADHD. Faraone SV; Glatt SJ; Bukstein OG; Lopez FA; Arnold LE; Findling RL J Atten Disord; 2009 Jan; 12(4):308-15. PubMed ID: 18400982 [TBL] [Abstract][Full Text] [Related]
56. Actigraphic monitoring during sleep of children with ADHD on methylphenidate and placebo. Schwartz G; Amor LB; Grizenko N; Lageix P; Baron C; Boivin DB; Joober R J Am Acad Child Adolesc Psychiatry; 2004 Oct; 43(10):1276-82. PubMed ID: 15381895 [TBL] [Abstract][Full Text] [Related]
57. Does placebo response differ between objective and subjective measures in children with attention-deficit/hyperactivity disorder? Sumner CR; Haynes VS; Teicher MH; Newcorn JH Postgrad Med; 2010 Sep; 122(5):52-61. PubMed ID: 20861588 [TBL] [Abstract][Full Text] [Related]
58. Lisdexamfetamine dimesylate improves processing speed and memory in cognitively impaired MS patients: a phase II study. Morrow SA; Smerbeck A; Patrick K; Cookfair D; Weinstock-Guttman B; Benedict RH J Neurol; 2013 Feb; 260(2):489-97. PubMed ID: 23001556 [TBL] [Abstract][Full Text] [Related]
59. Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse. Jasinski DR; Krishnan S J Psychopharmacol; 2009 Jun; 23(4):419-27. PubMed ID: 19329547 [TBL] [Abstract][Full Text] [Related]
60. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study. Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]